Lilit Voskoff
Staff Writer, The Fershman Journal
Lilit Voskoff is a Freshman writer for The Fershman Journal at the University of Chicago. She will primarily be writing about Mergers and Acquisitions (M&A) and market trends for The Fershman Journal. Her intended majors are Business Economics and Philosophy with a minor in Judaic Studies.
Lilit Voskoff
Staff Writer, The Fershman Journal
Lilit Voskoff is a Freshman writer for The Fershman Journal at the University of Chicago. She will primarily be writing about Mergers and Acquisitions (M&A) and market trends for The Fershman Journal. Her intended majors are Business Economics and Philosophy with a minor in Judaic Studies.
Lilit Voskoff
Staff Writer, The Fershman Journal
Lilit Voskoff is a Freshman writer for The Fershman Journal at the University of Chicago. She will primarily be writing about Mergers and Acquisitions (M&A) and market trends for The Fershman Journal. Her intended majors are Business Economics and Philosophy with a minor in Judaic Studies.

Lilit Voskoff — Articles

Lilit Voskoff — Articles

Lilit Voskoff — Articles

Taiwanese SL Bio Merges With Horizon Space Acquisition
Author Image

Lilit Voskoff

Feb 10, 2026

Once dismissed as speculative shortcuts, SPACs have evolved into a legitimate financing tool, especially for early-stage biotech. SL Bio’s $5.7B SPAC merger highlights why firms with long timelines and uncertain revenue may trade dilution and misaligned incentives for speed, certainty, and survival.

Taiwanese SL Bio Merges With Horizon Space Acquisition
Author Image

Lilit Voskoff

Feb 10, 2026

Once dismissed as speculative shortcuts, SPACs have evolved into a legitimate financing tool, especially for early-stage biotech. SL Bio’s $5.7B SPAC merger highlights why firms with long timelines and uncertain revenue may trade dilution and misaligned incentives for speed, certainty, and survival.

Taiwanese SL Bio Merges With Horizon Space Acquisition

Feb 10, 2026